Results 71 to 80 of about 1,266,459 (215)
Novel ORC4L Gene Mutation in B-Cell Lymphoproliferative Disorders
B-cell lymphoproliferative disorders are characterized by marked genetic, morphological, and clinical heterogeneity. The identification of prognostic markers could help to develop risk-adapted treatment strategies.
Ristić, Slobodan +5 more
core +1 more source
When Small Cells Matter: Diagnosing Bladder Small Cell Carcinoma on Urine Cytology
Small cell carcinoma of the bladder is rare, aggressive and diagnostically challenging on urine cytology. We report a case detected in urine and confirmed by cell block immunohistochemistry, highlighting the importance of careful assessment and limitations of the Paris System.
Haley Corbin +3 more
wiley +1 more source
Numerous Hot Topics in Lymphoproliferative Disorders
In the field of lymphoma, plenty of exciting abstracts were presented at the 2022 meeting of the American Society of Hematology (ASH). Hereby, we will focus on a few highlights, e.g.
Lang, Noémie, Novak, Urban
core
This retrospective study reviews 111 salivary gland fine‐needle aspiration cytology (FNAC) cases collected over an 11‐year period and reclassifies them according to the Milan System for Reporting Salivary Gland Cytopathology. Cytology‐histopathology correlation was performed for excision specimens, confirming the system's accuracy in distinguishing non‐
Shifa F. Khan +4 more
wiley +1 more source
Prevalence of hepatitis C virus in lymphoproliferative disorders [PDF]
Objective: To study the prevalence of hepatitis C virus in lymphoproliferative disorders. Methods: A case control prospective study was performed on 143 patients with lymphoproliferative disorders and 29 patients with non-hematological malignancies were ...
Zaidi, Y. +4 more
core
Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo
Summary Background and objectives Chronic pruritus (CP) and chronic prurigo (CPG, including prurigo nodularis) are prevalent, debilitating diseases with diverse comorbidities, including malignancies. This retrospective cohort study evaluated the prevalence and risk of lymphoma in CP and CPG patients, including key risk factors, and sex‐ and ancestry ...
Svenja Royeck +10 more
wiley +1 more source
The different face of skin‐rash induced by brentuximab vedotin
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri +11 more
wiley +1 more source
Introduction: Coronavirus disease 2019 (COVID-19) infection is associated with a variety of immune dysregulations. Aberrant immune function can lead to a plethora of lymphoproliferative and autoimmune dysfunctions.
Shiv Kumar +6 more
doaj +1 more source
Primary cutaneous lymphomas are defined as non-Hodgkin lymphomas that present in the skin with no evidence of extracutaneous disease at the time of diagnosis.
Lhara Sumarriva Lezama, Dita Gratzinger
core +1 more source
Inborn errors of immunity in children with neuroinflammation
Abstract Inborn errors of immunity (IEIs), an expanding group of monogenic disorders with diverse clinical manifestations, are increasingly recognized to include neuroinflammatory disease. Examples of diseases included under this umbrella are Aicardi–Goutières syndrome, deficiency of adenosine deaminase 2, familial haemophagocytic lymphohistiocytosis ...
Eppie M Yiu +5 more
wiley +1 more source

